Evaluation of the costs of topical treatments for actinic keratosis based on lesion response and the affected area

Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT

(2017) Piergiacomo Calzavara-Pinton et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

From actinic keratosis to squamous cell carcinoma: pathophysiology revisited

(2017) M.T. Fernandez Figueras   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study

(2016) C. Garbe et al.   BRITISH JOURNAL OF DERMATOLOGY

A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoL

(2016) U. Reinhold et al.   BRITISH JOURNAL OF DERMATOLOGY

Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis

(2016) Giovanni Genovese et al.   Dermatologic Therapy

A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp

(2016) Cristina Zane et al.   DERMATOLOGY

Actinic keratosis: correlation between clinical and histological classification systems

(2016) L. Schmitz et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update

(2016) Spencer M. Vale et al.   PHARMACOECONOMICS

A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp

(2016) Erica Moggio et al.   Photodiagnosis and Photodynamic Therapy

Thickness of Actinic Keratosis Does Not Predict Dysplasia Severity or P53 Expression

(2016) Ida M. Heerfordt et al.   Scientific Reports

Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses

(2016) Susan M. O’Gorman et al.   JAMA Dermatology

Cost–Utility of First-Line Actinic Keratosis Treatments in Finland

(2015) Erkki J. Soini et al.   ADVANCES IN THERAPY

Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe

(2015) J-P. Lacour et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp

(2014) C. Zane et al.   BRITISH JOURNAL OF DERMATOLOGY

Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate

(2014) N. Neittaanmäki-Perttu et al.   BRITISH JOURNAL OF DERMATOLOGY

Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial

(2014) D.M. Rubel et al.   BRITISH JOURNAL OF DERMATOLOGY

Management of actinic keratosis: a practical report and treatment algorithm from AKTeamTMexpert clinicians

(2014) B. Dréno et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Results of an Investigator-Initiated Single-Blind Split-Face Comparison of Photodynamic Therapy and 5% Imiquimod Cream for the Treatment of Actinic Keratoses

(2012) Jason Hadley et al.   DERMATOLOGIC SURGERY

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

(2011) T. Dirschka et al.   BRITISH JOURNAL OF DERMATOLOGY

Daylight photodynamic therapy for actinic keratosis: an international consensus

(2011) S.R. Wiegell et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

(2010) R.-M. Szeimies et al.   BRITISH JOURNAL OF DERMATOLOGY

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

(2010) Neil Swanson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

(2010) C. William Hanke et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Topical Methyl Aminolevulinate Photodynamic Therapy Using Red Light-Emitting Diode Light for Multiple Actinic Keratoses

(2009) Rolf-Markus Szeimies et al.   DERMATOLOGIC SURGERY

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study

(2008) David Pariser et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY